Review of Hyperuricaemia and Hypertension: A Target for Treatment
Claudine G Jennings*, Isla S Mackenzie and Thomas M MacDonald
Dundee University, Medicines Monitoring Unit, Ninewells Hospital, Dundee DD1 9SY, USA
- *Corresponding Author:
- Claudine Jennings
Medicine Monitoring Unit
Ninewells Hospital, Dundee, DD1 9SY, USA
Tel: 01382 383119
Fax: 01382 740209
E-mail: [email protected]
Received Date: June 20, 2014; Accepted Date: July 25, 2014; Published Date: August 03, 2014
Citation: Jennings CG, Mackenzie IS, MacDonald TM (2014) Review of Hyperuricaemia and Hypertension: A Target for Treatment. J Hypertens 3:164. doi:10.4172/2167-1095.1000164
Copyright: © 2014 Jennings C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Hypertension is a significant cardiovascular risk factor with multifactorial aetiology. The link between hypertension and hyperuricaemia has been noted for over a century however determining whether this link is causal and whether there is a role for management of hyperuriaemia in the context of hypertension has been more problematic. Over the past two decades research in this area has dramatically increased with development of animal models of hyperuricaemia and use of large observational cohorts. There is an emerging body of evidence that hyperuricaemia should be considered an independent risk factor for the development of essential hypertension and that further research into the management of hyperuricaemia is required.